Post

New research · Ophthalmology
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2d
Cohort studyGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026

Long-term structural impact and antiviral efficacy of cytomegalovirus anterior uveitis - results from a 10-year ocular inflammation registry.

Yung-Ray Hsu, Ming-Shan Cheng, Jia-Kang Wang
Read paper
OphthalmologyCohort study

High-dose topical antiviral therapy linked to fewer flare-ups in cytomegalovirus eye inflammation

Long-term structural impact and antiviral efficacy of cytomegalovirus anterior uveitis - results from a 10-year ocular inflammation registry.

Yung-Ray Hsu … Jia-Kang Wang
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
Purpose

To evaluate criteria-based long-term structural outcomes and dose-dependent antiviral effects in cytomegalovirus anterior uveitis (CMV AU).

Methods

From a 10-year ocular inflammation registry comprising 1,404 patients, 79 eyes from 67 patients with PCR-confirmed CMV AU were identified (mean follow-up, 48 ± 38 months).

n = 1,404 patients
Results

high-dose therapy cut eye flare-ups more than low-dose treatment

30.3%
Before
62%
After
More results

The mean age was 56.5 ± 15.5 years, and 82.1% had unilateral disease.

Median diagnostic delay was 33 months; 20.9% required repeat aqueous taps.

Glaucoma rose from 30.3% to 62.0% and ECCD loss from 27.8% to 57.0% during follow-up.

Kaplan-Meier analysis showed a median time of 9 years from symptom-onset to manifest glaucoma.

“
Conclusion

CMV AU poses significant long-term structural risk despite good short-term control. Early criteria-based treatment and high-dose antivirals reduce relapse, while lifelong maintenance is required in eyes with advanced disease.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment